Danny T. Huang
- Oncology top 2%
- Cancer-related Molecular Pathways 14
- Peptidase Inhibition and Analysis 6
- Molecular Biology top 2%
- Ubiquitin and proteasome pathways 32
- Protein Degradation and Inhibitors 9
- Glycosylation and Glycoproteins Research 8
- Biochemical and Molecular Research 6
- Cancer-related gene regulation 4
- Cell Biology top 5%
- Epidemiology top 5%
- Autophagy in Disease and Therapy 7
- Parasitology top 5%
- Co-authors
- Lori BuetowBrenda A. SchulmanGary SibbetHao DouJames M. HoltonKenneth CameronMin ZhuangDavid M. Duda
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Danny T. Huang
44 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 1.1k
- Molecular Biology 2.5k
- Cell Biology 333
- Epidemiology 566
- Parasitology 103
Countries citing papers authored by Danny T. Huang
This map shows the geographic impact of Danny T. Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny T. Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny T. Huang more than expected).
Fields of papers citing papers by Danny T. Huang
This network shows the impact of papers produced by Danny T. Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny T. Huang. The network helps show where Danny T. Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danny T. Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 12 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 4 | |
| 8 | 2022 | 30 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 8 | |
| 11 | 2021 | 2 | |
| 12 | 2020 | 67 | |
| 13 | 2020 | 55 | |
| 14 | 2020 | 28 | |
| 15 | 2018 | 9 | |
| 16 | 2018 | 15 | |
| 17 | 2017 | 53 | |
| 18 | 2016 | 15 | |
| 19 | 2016 | 17 | |
| 20 | 2003 | 225 |
About Danny T. Huang
Danny T. Huang is a scholar working on Oncology, Molecular Biology and Physiology, having authored 49 papers that have together received 2.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (32 papers), Cancer-related Molecular Pathways (14 papers), Protein Degradation and Inhibitors (9 papers), Glycosylation and Glycoproteins Research (8 papers), Autophagy in Disease and Therapy (7 papers), Biochemical and Molecular Research (6 papers), Peptidase Inhibition and Analysis (6 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Oncology (1.1k citations), Molecular Biology (2.5k citations) and Cell Biology (333 citations). Danny T. Huang has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Lori Buetow, Brenda A. Schulman, Gary Sibbet, Hao Dou, James M. Holton, Kenneth Cameron, Min Zhuang, David M. Duda, David W. Miller and Helen Walden. Their work appears in journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.